1. Home
  2. Science & Technology
  3. Sacramento, CA
  4. California Biotechnology Foundation

California Biotechnology Foundation

California Biotechnology Foundation has an America's Best Score of 51 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Sacramento, CA
  • Tax-exempt since 2010
  • EIN: 77-0720482
cabiotech.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
51OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

California Biotechnology Foundation is a 501(c)(3) organization, classified under Science & Technology (NTEE U99). Contributions are tax-deductible.

1215 K St Ste 970, Sacramento, CA 95814-3946

Among the 8 scored science & technology organizations in Sacramento, California Biotechnology Foundation holds 0 months of operating reserves (peer median 8 months), runs a typical yearly deficit of 1.0% (peers: deficit of 1.1%), and has cut spending 8.0% a year (peers: grown spending 26.9% a year).

In fiscal year 2025 it reported $737,331 in revenue and $701,655 in expenses, with contributions making up 100.0% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The primary objectives and purposes of corporation shall be to educate the public concerning biotechnology and healthcare - related fields

Main program · fiscal year 2025

  • As one of the most research intensive industries in the world, California biotech companies invest in discoveries for medicines and devices that shape the future of healthcare throughout the world.Biotech creates treatments and cures for diseases that were once considered a death sentence. At the state level, California is particularly competitive in Biopharmaceutical Manufacturing; Medical Device… Read more

    As one of the most research intensive industries in the world, California biotech companies invest in discoveries for medicines and devices that shape the future of healthcare throughout the world.Biotech creates treatments and cures for diseases that were once considered a death sentence. At the state level, California is particularly competitive in Biopharmaceutical Manufacturing; Medical Devices and Diagnostic Equipment; and Research activities.

    $561,325 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 80¢ went to programs, 20¢ to management and 0¢ to fundraising.

  • Programs $561,325
  • Management $140,330
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score51 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves0.0 mo; 0.0 mo in cash0 / 25
Financial balance (median margin)−1.0%11 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth−8.0% / yr3.5 / 15
Track record16 years6.4 / 10
Debt load0.0% of assets10 / 10
Total50.9 → 51
Spending on programs
Not scored; America's Best needs 65%+
80%Meets

Compared with Sacramento peers

MeasureThis organizationPeer median
Operating reserves0.0 mo8.0 mo
Typical margin−1.0%−1.1%
Spending growth−8.0% / yr+26.9% / yr
Debt load0.0%15.5%

Peers: the 8 Sacramento science & technology organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$737,331Fiscal year 20252022: $872,55020222023: $773,00220232024: $655,21420242025: $737,3312025
Expenses$701,655Fiscal year 20252022: $899,73920222023: $765,26220232024: $738,70920242025: $701,6552025
Total assets$582Fiscal year 20252022: $40,66120222023: $48,40120232024: −$35,09420242025: $5822025
Total liabilities$0Fiscal year 20252022: $020222023: $020232024: $020242025: $02025
Fiscal year ending December 2025
Revenue$737,331
Expenses$701,655
Net income$35,676
Net assets$582

Notable sources of revenue

Percent of total revenue
Contributions$737,331
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$582
Total liabilities$0
Net assets$582

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$655,214
Expenses$738,709
Net income−$83,495
Net assets−$35,094

Notable sources of revenue

Percent of total revenue
Contributions$655,214
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets−$35,094
Total liabilities$0
Net assets−$35,094

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$773,002
Expenses$765,262
Net income$7,740
Net assets$48,401

Notable sources of revenue

Percent of total revenue
Contributions$773,002
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$48,401
Total liabilities$0
Net assets$48,401

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$872,550
Expenses$899,739
Net income−$27,189
Net assets$40,661

Notable sources of revenue

Percent of total revenue
Contributions$872,550
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$40,661
Total liabilities$0
Net assets$40,661

Compensation

Officers and key employees$207,162
Share of expenses23.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?